The fundamentals of Koru medical story remain positive. The covid-19 pandemic strengthened the argument for home subcutaneous immunoglobulin infusion. It is cheaper, more convenient, with less patient side effects. For these reasons, when possible, other medications are or will be reconfigured for home subq infusions.
I believe the company is developing a digital flow monitoring system. It will allow remote monitoring and verification that patients are doing the infusions. I see the system as a important part of the KRMD's partnership with drug companies. Remote monitoring will improve the quality and integrity of the data being collected. When introduced for home infusion will provide a nice revenue stream. LOOK FOR A PATENT HERE!!